ABSTRACT The superficial ocular vasculature of the embryonic zebrafish develops in a highly stereotypic manner and hence provides a convenient model for studying molecular mechanisms that regulate vascular patterning. We have used transgenic zebrafish embryos in which all endothelial cells express enhanced Green Fluorescent Protein and small molecule inhibitors to examine the contribution of two signaling pathways, vascular endothelial growth factor (VEGF) and Hedgehog (Hh) pathways, to the development of the superficial system. We find that most, but not all vessels of the superficial system depend on VEGF signaling for their growth. Hh signaling appears to limit superficial vessel growth over the dorsal eye and is required to promote superficial vessel growth over the ventral eye. These effects of Hh signaling are indirect. Our initial analyses of factors that regulate growth and patterning of superficial ocular vessels suggest that early patterning events in the embryo during organogenesis stages could influence vascular patterning later on. By studying development of specific vascular systems it should be possible to identify new roles for signaling pathways in regulating vascular development.
Introduction
The embryonic vertebrate eye receives blood supply from two networks of blood vessels: the hyaloid system inside the eye and the choroidal vasculature on the outer surface (Saint-Geniez and D'Amore, 2004) . In zebrafish, the first vessels that supply blood to the outer surface of the eye form a highly stereotypic and simple pattern, which we have named the superficial ocular vasculature (Kaufman et al., 2015) . The initial pattern of superficial ocular vasculature is completed by approximately 54 hours post fertilization (hpf) and includes one vessel that serves as an artery, the nasal radial vessel (NRV), which receives blood through the cranial division of the carotid artery (CrDI). Blood is drained from the system via two veins, the dorsal radial vessel (DRV) and the ventral radial vessel (VRV), the latter also draining the hyaloid system. NRV, DRV and VRV are interconnected by the superficial annular vessel (SAV) (see Fig. 1 ) (Kaufman et al., 2015; Kitambi et al., 2009) . The superficial ocular system begins to develop at 22-23 hpf and is entirely derived from a single venous source, the primordial midbrain channel (PMBC) (Kaufman et al., 2015) .
The highly stereotypic pattern in which superficial ocular vessels of zebrafish develop begs the question of how formation of this pattern is directed. Two main processes underlie the formation of new blood vessels, namely vasculogenesis and angiogenesis. In vasculogenesis, angioblasts, the precursors of endothelial cells, coalesce at a specific region where they differentiate into endothelial cells and rearrange to form new blood vessels. In angiogenesis, new blood vessels arise from an existing vessel, either by sprouting of new vessels (sprouting angiogenesis) or by splitting of the vessel (intussusceptive angiogenesis) (Ellertsdottir et al., 2010; Heinke et al., 2012) . All ocular vessels in zebrafish form by angiogenesis (Hartsock et al., 2014; Kaufman et al., 2015) , whereas the PMBC, which gives rise to superficial vessels forms by vasculogenesis (Proulx et al., 2010) .
Angiogenesis is a complex process, requiring formation of sprouts at correct locations, endothelial cell proliferation, guided migration of the growing vessel and differentiation and maturation of the new vessel as artery or vein (Carmeliet, 2003) . Vascular endothelial growth factor (VEGF) family of ligands and receptors (VEGFRs) is the central regulator of angiogenesis, and promotes endothelial cell proliferation, migration and arterial fate. VEGF-A signaling through VEGFR-2 (Kdr, Flk-1) is the main pro-angiogenic mechanism (Carmeliet et al., 1996; Ferrara et al., 1996; Shalaby et al., 1995) , but other family members, e.g. VEGF-B, VEGF-C and VEGFR-3 (Flt-4) have also been shown to promote angiogenesis in specific contexts (Covassin et al., 2006; Jensen et al., 2015; Ober et al., 2004) .
In addition to VEGF, other signaling pathways can also promote angiogenesis. The Hedgehog (Hh) signaling pathway has been shown to promote angiogenesis upstream of VEGF expression in several contexts (Nagase et al., 2008; Pola et al., 2001) , and also during arterial differentiation (Lawson et al., 2002) . Hh signaling can also promote angiogenesis by acting directly on endothelial cells (Chinchilla et al., 2010; Renault et al., 2010) . However, whether Hh signaling affects, either directly or indirectly, vascular patterning is currently unknown.
In this work we begin to address the question of what are the molecular signals that help to shape the superficial ocular vasculature in zebrafish. We first examine the implications of blocking VEGF signaling and find that almost all ocular vessels require VEGF signaling for their growth and early maintenance. Surprisingly, growth of vessels arising from the ventral PMBC appears independent of VEGF signaling. We then examine whether Hh signaling contributes to promoting angiogenesis upstream of VEGF. Surprisingly, we find that reduced Hh pathway activity leads to excess angiogenesis over the dorsal eye and failure of blood vessel formation over the ventral eye. The effect of loss of Hh signaling on superficial vessel angiogenesis is indirect and is only partially dependent on VEGF signaling. Together, the results described in this work begin to identify signaling pathways that are required for proper formation of ocular vessels in zebrafish and raise the idea that early patterning events during organogenesis influence later-developing patterns of blood vessels.
Results

VEGF signaling is required for development and early survival of most ocular vessels
To begin to identify the mechanisms that govern patterning of superficial ocular vessels in zebrafish, we asked what signals drove growth of these vessels. VEGF signaling is known for promoting angiogenesis in multiple contexts; however, recent work has shown that in the trunk of zebrafish embryos, Bone Morphogenetic Signaling (BMP) signaling drove venous angiogenesis whereas VEGF signaling drove arterial angiogenesis (Wiley et al., 2011) . Given that all superficial vessels are derived from a vein, the PMBC, we asked which signaling pathway drove their growth. To examine the contribution of these signaling pathways to ocular angiogenesis we used small molecule inhibitors to block VEGF or BMP signaling and analyzed the development of ocular vessels in Tg(kdrl:EGFP) embryos, in which all endothelial cells express EGFP under regulation of vegfr-2 promoter/enhancer elements, thus affording visualization of the vasculature in live embryos.
Ocular vessels in zebrafish begin growing around 18 hpf, starting with the hyaloid artery that later grows to form the arterial components of the hyaloid system and following with growth from the PMBC around 20 hpf (Kaufman et al., 2015) . The PMBC itself becomes apparent in Tg(kdrl:EGFP) embryos only around 18 hpf. To block VEGF signaling we treated embryos with the VEGFR inhibitor SU5416, which has been shown to efficiently block angiogenesis (Fong et al., 1999; Serbedzija et al., 1999) , starting at 17 hpf (16 somite-stage) and examined vessel development at 30 hpf and 50 hpf. Whereas in control embryos superficial vessels appeared normal at 30 hpf (n=6/6), in treated embryos superficial vessels completely failed to develop (n=15/15) ( Fig. 2 A,B) . Moreover, CrDI and hyaloid vessels also did not form. By contrast, the PMBC did form and surprisingly, a rudimentary VRV was observed in the treated embryos, suggesting that PMBC and VRV formation were VEGF-independent (Fig. 2B) . By 50 hpf, in SU5416-treated embryos there was no appreciable growth of dorsal superficial vessels, and the PMBC appeared to be disintegrating. In most of the embryos the VRV and a rudimentary hyaloid vein were present (n= 12/14) (Fig. 2D) .
In contrast to inhibition of VEGF signaling, a similar experiment in which BMP signaling was blocked using the specific BMP inhibitor DMH1 (Hao et al., 2010) showed that blocking BMP signaling results in abnormal superficial vessel patterning, but does not inhibit the growth of these vessels or of hyaloid vessels (n=13/16) ( Fig. 2 E,F) .
These results suggest that ocular vessel development largely depends on VEGF signaling, however formation of vessels originating in the ventral PMBC appears to be VEGF-independent.
Next, we examined whether components of the VEGF pathway were expressed in the developing eye and ocular vessels. Expression of VEGF receptors kdrl (vegfr-2) and flt-4 (vegfr-3) in the PMBC, which gives rise to all superficial vessels, has been described (Thisse et al., 2001) . We examined expression of VEGF ligands vegfaa and vegfab. vegfaa was expressed in the developing eye during stages of ocular vessel development (24 hpf and 30 hpf), with expression mostly localized in the periphery of the lens 
B) Bright field image of the eye from the embryo imaged in (A). (C) Overlay of (A,B) to show localization of vessels relative to eye tissues. Arrows in (A) point at the superficial annular vessel (SAV)
. DRV, dorsal radial vessel; H, hyaloid vessels; L, lens; NR, neural retina; NRV, nasal radial vessel; PMBC, primordial midbrain channel; VRV, ventral radial vessel. Lateral view, anterior to the left. Scale bar, 50 mm.
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( Fig. 3 A,B) . vegfab was weakly expressed in the optic (choroid) fissure region ( Fig. 3 C,D) . vegfc and vegfd do not appear to be expressed in or near the developing eye during the time ocular vessels develop (Astin et al., 2014; Ober et al., 2004) 
(our unpublished observations).
VEGF signaling is required for survival of ocular vessels only at early developmental stages VEGF signaling is required not only to promote angiogenesis but also for survival of endothelial cells (Alon et al., 1995) . To find whether superficial ocular vessels required VEGF signaling for their survival we treated embryos with the VEGFR-2 inhibitor 1-[4-(6,7-Dimethoxy-quinolin-4-yloxy)-3-fluoro-phenyl]-3-(2-fluorophenyl)-urea (Ilovich et al., 2008) , hereafter referred to as U7, at different time windows and examined the effect on ocular blood vessels. This VEGFR-2 inhibitor was used in this work interchangeably with SU5416 and gave the same results. Ocular vasculature was documented just prior to treatment and imaged again at the end of the treatment. The first time window of treatment was between 18 and 25 hpf. At 18 hpf, ocular vessels have not formed yet and the PMBC was not detected. Only the hyaloid artery was observed beginning to grow inside the eye (Fig. 4 A,B). After blocking VEGF signaling from 18 hpf until 25 hpf, consistent with the data described above when using SU5416, the PMBC formed but no sprouting of DRV was observed and only a rudimentary VRV could be seen (n=7/7), whereas in control embryos the DRV has begun growing (n=6/7) (Fig. 4 A',B' ). Next we blocked VEGF signaling from 27 hpf, when the DRV has already sprouted (Fig. 4 C,D) , until 47 hpf, a time point when in control embryos most superficial ocular vessels have already formed, including DRV, NRV, VRV and anterior SAV (n=11/11) (Fig. 4C') . In treated embryos, whereas at 27 hpf a well-developed DRV was observed (Fig. 4D) , at 47 hpf almost none of the vessels could be detected, and only a remnant of the VRV was present (n=9/9) (Fig. 4D') , indicating that VEGF signaling was also required for the survival of newly formed superficial vessels. Finally, we blocked VEGF signaling from 45 hpf, when much of the superficial system has formed except the posterior SAV (Fig.  4 E,F) until 62 hpf, when the superficial system has fully formed. Whereas in control embryos superficial vessels have generated DRV, dorsal radial vessel; H, hyaloid vessels; HV, hyaloid vein; NRV, nasal radial vessel; PMBC, primordial midbrain channel; VRV, ventral radial vessel the final pattern (n=7/7), in treated embryos development of the superficial system was arrested and remained as it was at 45 hpf (n=7/7) (Fig. 4 E',F,F' ). Importantly, vessels did not degrade, suggesting that from 45 hpf and possibly even earlier, superficial vessels no longer require VEGF signaling for their survival.
Together, the results show that consistent with known functions of VEGF signaling, it is required for the formation of most superficial ocular vasculature and for the survival of these vessels only during the stages shortly after they have formed.
Loss of Hedgehog signaling results in excess sprouting from the PMBC and abnormal superficial vessel patterning
We next asked which additional signaling pathways might influence superficial vessel development. We chose to examine the effect of Hh signaling because it has been shown to positively regulate VEGF signaling in several contexts and it also influences eye development. To find whether and how Hh signaling affected superficial vessel development we used smoothened (smo) mutant embryos, in which activity of Smoothened, the obligatory mediator of Hh signaling, is missing (Varga et al., 2001) . Surprisingly, we found that in smo mutants, sprouting from the PMBC was increased. At 27 hpf, in normal embryos 1-2 sprouts from the PMBC give rise to 1-2 DRVs (Kaufman et al., 2015) (Fig. 5A) . By contrast, in mutant embryos we observed up to six sprouts, which gave rise to an ectopic network of vessels over the dorsal aspect of the developing eye (n=19/19) (Fig. 5 B,C,F) . By 54 hpf, when development of the superficial system is complete (Fig. 5D ), in smo mutants the abnormally patterned ectopic network of vessels persisted over the dorsal eye whereas vessels failed to grow over the ventral eye (n=15/15) (Fig. 5E ). Hence, in the absence of Hh activity superficial vessel patterning is abnormal, suggesting a role for Hh signaling in limiting angiogenesis from the dorsal PMBC and in promoting vascular development over the ventral eye.
vessel (SAV) was arrested and arrowhead points at a hyaloid vessel. In (C' , E, E' , F, F' ) hyaloid vessels are not shown to help focus on superficial vasculature. All panels are lateral views, anterior to the left. DRV, dorsal radial vessel; H, hyaloid vessels; NRV, nasal radial vessel; PMBC, primordial midbrain channel; VRV, ventral radial vessel. Scale bars, 50 mm.
Fig. 5. Excess superficial vessel sprouting in smo mutant embryos. (A-E) Confocal maximum projection images of superficial ocular vasculature in live normal or smo mutant embryos carrying kdrl:EGFP transgene, at 27 hpf (A-C) or 54 hpf (D,E). Asterisks in (A-C) mark exit points of sprouts from the PMBC. (F) Quantification of the number of sprouts from dorsal PMBC in smo mutants versus normal siblings at 27 hpf. The difference in the number of sprouts is statistically significant (Students's t-test). In all images, anterior is left and dorsal up. DRV, dorsal radial vessel; H, hyaloid vessels
Hedgehog functions indirectly to influence ocular vessel patterning
Because Hh ligands are not expressed near the dorsal PMBC during the time of sprouting (Ekker et al., 1995; Krauss et al., 1993) , we hypothesized that the effect of Hh on ocular angiogenesis was indirect. To test this hypothesis we interfered with Hh signaling during different time windows and assayed development of superficial ocular vessels. The rationale of this experiment is that if Hh signaling directly affected vessel growth, then blocking Hh signaling around the time of sprouting from the PMBC would lead to a similar phenotype to smo mutants. Alternatively, if Hh signaling acted indirectly, then in order to phenocopy the smo mutant phenotype one would need to interfere with Hh signaling before vessel sprouting. To block Hh signaling we used the small molecule cyclopamine, which inhibits Smo function . For all time points of control and treatment, results represent at least 10 embryos. When embryos were treated with cyclopamine from gastrulation stages (6-10 hpf) and assayed at 27-29 hpf and at 48-50 hpf, superficial vessels showed similar phenotypes to those of smo mutants at both time points (Fig. 6  B,F,I ). When embryos were treated from 14 hpf (12 somite stage), their superficial vasculature appeared relatively normal at 27-29 hpf, but phenocopied smo mutants at 48-50 hpf (Fig. 6 C,G,J) . When treatment was initiated at 18 hpf, superficial vessels developed normally at both time points (Fig. 6 D,H,K) . Since sprouting from the PMBC starts only at 22-23 hpf, these data are consistent with the idea that Hh signaling influences sprouting and patterning of superficial vessels indirectly.
Excess sprouting in smo mutants is only partially VEGFdependent
The excessive sprouting from the PMBC in smo mutant embryos is surprising given that, to date, Hh signaling was found to be proangiogenic. As Hh pathway activity can regulate VEGF expression and ocular vessel growth is largely dependent on VEGF signaling, we next asked whether and how expression of VEGF ligands was affected in smo mutants. In situ hybridization for vegfaa showed clear reduction of expression in the trunk region compared to normal (Fig. 7 B,D) , as previously described (Lawson et al., 2002) , however, expression levels in the head and eye region appeared much less affected (Fig. 7 A,C) . vegfab expression also appeared largely unaffected in the head and eye regions (Fig. 7 E,G) , whereas in the trunk region it appeared somewhat elevated ( Fig. 7 F,H) . Hence, Hh activity does not appear to play a major role in regulating relevant VEGF pathway ligand expression in the head region.
Next, we blocked VEGF signaling in smo mutant embryos by treating them with SU5416 from 18 hpf and assayed ocular vessel development at 30 hpf and 50 hpf. Surprisingly, treated smo mutant embryos showed at 30 hpf some sprouting from the PMBC over the dorsal eye, whereas their treated normal siblings, similar to treated wild-type embryos, had no sprouting (Fig. 8 B,C,G) . Although sprouts were present in smo mutant embryos, they were underdeveloped compared to untreated embryos (Fig. 8B) . At 50 hpf, sprouts of treated smo mutant embryos continued to develop, while treated siblings showed degeneration of vasculature. At both time points, treated smo mutant embryos had significantly 
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A G more sprouts than treated normal siblings, but significantly less than untreated smo mutant embryos (Fig. 8G ). This result suggests that excessive sprouting in embryos lacking Hh signaling is only partially dependent on VEGF activity. The mechanism that enables angiogenesis when VEGF activity is blocked remains to be determined.
Discussion
In this work we examine the contributions of VEGF and Hh signaling pathways to formation and patterning of superficial ocular vessels in zebrafish. We find that VEGF signaling is required to promote growth and survival of newly formed ocular vessels, with exception of vessels that originate in the ventral PMBC. Hh signaling is not required for superficial vessels growth but is required for their correct patterning.
Although VEGF signaling is the pathway most commonly implicated in promoting angiogenesis, other signaling pathways have been shown to promote vascular growth independently of VEGF. For example, Bone morphogenetic protein (BMP) signaling has been shown to promote venous sprouting angiogenesis in the zebrafish trunk, whereas VEGF signaling promoted arterial sprouting angiogenesis (Wiley et al., 2011) . However, we find that even though the entire superficial vasculature is derived from a venous source, the PMBC, it is largely dependent on VEGF for its development by angiogenesis. Only vessels derived from the ventral PMBC, i.e. the VRV and hyaloid venous vessels appear to develop independently of VEGF signaling. It is interesting to note that the growth of these vessels from the ventral PMBC appears somewhat different from angiogenesis from the dorsal PMBC as endothelial cells originating from the ventral PMBC form a thin chain of cells that reaches the ventral aspect of the eye, near the optic fissure (Kaufman et (A,B,E,F) and smo mutant (C,D,G,H) embryos. (A,C,E,G) show expression in the head region, (B,D,F,H , 2015) . This appears different from the sprouts arising from the dorsal PMBC that have a prominent tip cell, as also described in other contexts. It is possible that the different appearance correlates with a different molecular mechanism underlying the angiogenic process from the ventral PMBC. What is the molecular mechanism that promotes angiogenesis from the ventral PMBC remains to be determined. We have ruled out Hh, Fibroblast growth factor (FGF) and BMP signaling (Weiss, Kaufman and Inbal, unpublished observations (Helker et al., 2015) and their potential role needs to be examined. The lack of Hh signaling resulted in a surprising effect on ocular vessels. Given that Hh is known to function as a pro-angiogenic factor, we expected that if it had a role in ocular vessel development, its loss of function would lead to reduced angiogenesis. However, we observed the opposite effect over the dorsal eye, namely increased sprouting from the dorsal PMBC. Over the ventral eye vessels failed to grow, which is consistent with a pro-angiogenic role of Hh. These opposite effects are indirect, hence, they are mediated by another process that takes place by mid-late segmentation stages. One possible candidate process is eye patterning, which is largely completed by the time superficial vessels begin to form at approximately 22-23 hpf. Both dorsoventral and nasotemporal patterning of the eye are influenced by Hh signaling (Ekker et al., 1995; Hernandez-Bejarano et al., 2015; Lupo et al., 2005; Takeuchi et al., 2003) . We hypothesize that the stereotypic growth of superficial ocular vessels, which takes place over the surface of the eye, is at least in part directed by the molecular landscape of the eye. If this hypothesis is correct, abnormal eye patterning could lead to abnormalities in superficial vessel patterning. Hence, it is possible that eyes of Hh-deficient embryos, which have been shown to be abnormally patterned, mediate the effect of Hh signaling on superficial vessel development. Alternatively, abnormalities of other adjacent structures due to lack of Hh activity, such as brain tissues or the surface ectoderm in the eye region, could also influence ocular vessel development. At the molecular level, it is possible that factors that restrict angiogenesis such as, for example, PlexinD1 (Childs et al., 2002; Torres-Vazquez et al., 2004) are reduced in the dorsal PMBC or eye region in Hh-deficient embryos. The exact mechanism through which Hh influences ocular vessel patterning will likely remain unclear until better understanding of the direct signals that underlie ocular vessel patterning is achieved.
Materials and Methods
Fish lines and husbandry
Zebrafish (Danio rerio) were maintained according to standard procedures on a 14 hour light/10 hour dark cycle at 28.5°C and embryos were staged as previously described (Kimmel et al., 1995) . The following published lines were used in this work: Tg(kdrl:EGFP)s843 (Jin et al., 2005) , smoothened null allele smob641 (Varga et al., 2001) . AB and TL lines were used as wild type. All experiments were approved by the Hebrew University Authority for Biological and Biomedical Models.
In situ hybridization
Whole-mount in situ hybridization (WISH) using riboprobes was performed according to standard protocols (Thisse and Thisse, 2008) . BM Purple (Roche) was used as color substrate.
Probes used in this work were vegfaa (Liang et al., 2001) ; vegfab: vegfab coding sequence was PCR amplified from wild-type total cDNA, cloned into pGEM-T Easy vector (Promega) and confirmed by sequencing. The plasmid was linearized using NcoI and RNA was transcribed using SP6 RNA polymerase.
Small molecule treatments
To block VEGF signaling we used interchangeably two VEGFR-2 inhibitors: SU5416 (Sigma-Aldrich #S8442) was dissolved in DMSO and was used at 1 mM and 1-[4-(6,7-Dimethoxy-quinolin-4-yloxy)-3-fluoro-phenyl]-3-(2-fluoro-phenyl)-urea (Ilovich et al., 2008) was dissolved in DMSO and was used at 500 nM. DMH1 (Sigma-Aldrich #D8946) was dissolved in DMSO and was used at 10 mM. Cyclopamine (Sigma-Aldrich #C4116) was dissolved in EtOH and used at 10 mM.
Imaging
To block pigmentation when imaging embryos older than 24 hpf, embryos were raised from 22 hpf in the presence of 0.003% N-Phenylthiourea (PTU; Sigma-Aldrich #P7629). Live embryos were anaesthetized using tricaine and mounted in 0.5% low-melting-point agarose (SeaPlaque, Lonza).
Images were acquired using Zeiss LSM700 confocal microscope and Axio Imager.M2 compound microscope or with Discovery.V8 stereoscope and AxioCam MRc digital camera (Zeiss). Microscope objectives used were 40x 1.0 NA water objective or 25x 0.8 NA or 10x 0.3 NA. Images were exported as JPEG or TIFF files using ZEN 2009 LE software (Zeiss) and figures were assembled using Adobe Photoshop CS4 software.
Quantification and statistical analysis
Quantification of dorsal sprouts of superficial vessels was performed by manually counting exit points of sprouts from the PMBC in 3D reconstructions of confocal image data. Statistical analysis was done using Student's t-test.
